C4 Therapeutics, Inc. - Common Stock (CCCC)
1.5200
+0.0850 (5.92%)
NASDAQ · Last Trade: Apr 2nd, 7:16 PM EDT

Via Benzinga · December 19, 2024

Via Benzinga · September 9, 2024

Via Benzinga · September 9, 2024

CCCC stock results show that C4 Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 1, 2024

Via Benzinga · February 26, 2024

CCCC stock results show that C4 Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 50 points on Tuesday.
Via Benzinga · February 20, 2024

These stocks to buy for growth already have a strong growth story. If they reach their potential investors could see some dynamic returns.
Via InvestorPlace · January 22, 2024

C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past five days.
Via Benzinga · December 15, 2023

A look at five stocks that saw increased interest from Benzinga readers during the week.
Via Benzinga · December 15, 2023

Via Benzinga · December 15, 2023

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74. The S&P 500 also rose, gaining, 0.62% to 4,672.48.
Via Benzinga · December 13, 2023

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.
Via Benzinga · December 13, 2023

Via Benzinga · December 13, 2023

U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose, gaining, 0.20% to 4,653.07.
Via Benzinga · December 13, 2023

U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to 14,594.61. The S&P 500 also rose, gaining, 0.14% to 4,650.04.
Via Benzinga · December 13, 2023

C4 Therapeutics Inc (NASDAQ: CCCC) shares are trading higher Wednesday after the company presented data from a Phase 1 trial for the p
Via Benzinga · December 13, 2023

Via Benzinga · December 13, 2023

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.
Via Benzinga · December 13, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · December 13, 2023

Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!
Via InvestorPlace · December 13, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday. The Dow traded up 0.32% to 36,520.57 while the NASDAQ rose 0.46% to 14,498.23. The S&P 500 also rose, gaining, 0.26% to 4,634.47.
Via Benzinga · December 12, 2023

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.
Via Benzinga · December 12, 2023